E-LIB Suche - Ergebnisse für: Lou, Yinjun

1

Venetoclax plus cytarabine and azacitidine in relapsed/refr..:

You, Liangshun ; Liu, Yi ; Mai, Wenyuan...
European Journal of Cancer. 202 (2024) - p. 113979 , 2024

Link: https://doi.org/10.1016/..

2

Venetoclax plus daunorubicin and cytarabine in newly diagno..:

Wang, Rong ; Zhang, Yi ; Chang, Jie...
Hematological Oncology. 42 (2024) 2 - p. , 2024

Link: https://doi.org/10.1002/..

3

Clinical characteristics of acute myeloid leukaemia patient..:

Zhao, Shuqi ; Wang, Jinghan ; Lou, Yinjun...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

4

Venetoclax plus '2 + 5' modified intensive chemotherapy wit..:

Wang, Huafeng ; Yao, Yiyi ; Mao, Liping...
British Journal of Haematology. 201 (2023) 3 - p. 568-572 , 2023

Link: https://doi.org/10.1111/..

5

New insights into the clinical characteristics of SETD2‐mut..:

Zhang, Xiang ; Wang, Ziwei ; Sun, Jiewen...
British Journal of Haematology. 202 (2023) 1 - p. 111-115 , 2023

Link: https://doi.org/10.1111/..

6

Frontline Management of Elderly Acute Myeloid Leukemia Inel..:

, In: Pathogenesis and Treatment of Leukemia,

Lou, Yin-Jun ; Jin, Jie ; Zhu, Hong-Hu - p. 111-118 , 2023

Link: https://doi.org/10.1007/..

7

The clinical impact of IKZF1 mutation in acute myeloid leuk..:

Zhang, Xiang ; Huang, Aijie ; Liu, Lixia...
Experimental Hematology & Oncology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

8

Gilteritinib‐based combination therapy in adult relapsed/re..:

Chen, Nianci ; Pan, Jiajia ; Zhou, Yile...
British Journal of Haematology. 204 (2023) 3 - p. 861-870 , 2023

Link: https://doi.org/10.1111/..

9

P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY ..:

Wang, Huafeng ; Yang, Min ; Tong, Hongyan...
HemaSphere. 7 (2023) S3 - p. e8847288 , 2023

Link: https://doi.org/10.1097/..

10

Transcriptome-wide subtyping of pediatric and adult T cell ..:

Dai, Yu-Ting ; Zhang, Fan ; Fang, Hai...
Proceedings of the National Academy of Sciences. 119 (2022) 15 - p. , 2022

Link: https://doi.org/10.1073/..

11

Oral arsenic and retinoic acid for high-risk acute promyelo..:

Ma, Ya-Fang ; Lu, Ying ; Wu, Qian...
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Distinct outcomes, ABL1 mutation profile, and transcriptome..:

Shi, Ting ; Xie, Mixue ; Chen, Li...
Experimental Hematology & Oncology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

13

Minimal residual disease level determined by flow cytometry..:

Wang, Huanping ; Zhou, Yile ; Huang, Xin...
British Journal of Haematology. 193 (2021) 6 - p. 1096-1104 , 2021

Link: https://doi.org/10.1111/..

14

Arsenic trioxide replacing or reducing chemotherapy in cons..:

Chen, Li ; Zhu, Hong-Ming ; Li, Yan...
Proceedings of the National Academy of Sciences. 118 (2021) 6 - p. , 2021

Link: https://doi.org/10.1073/..

15

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid fo..:

Lou, Yinjun ; Ma, Yafang ; Jin, Jie.
Frontiers in Oncology. 10 (2021) - p. , 2021

Link: https://doi.org/10.3389/..